Aker BioMarine appoints EVP of human health & nutrition

Simon Seward, previously SVP QRILL Aqua in Aker BioMarine, has been appointed the head of the company’s Human Health & Nutrition business.

With broad experience from the nutraceutical and aquaculture sectors, Seward has been appointed EVP of Human Health & Nutrition in Aker BioMarine. In his role, he will lead the company’s ambitious growth strategy for the Superba brand. Seward began working for Aker BioMarine in 2019 with the responsibility to grow QRILL Aqua sales in Asia and subsequently to lead global sales to the aquaculture sector.

Seward brings an in-depth knowledge base of the global B2B nutritional market to this position. Prior to working at Aker, he worked with the Norwegian human nutrition group, Sana Pharma Holding, in various management roles, including the launch of the Algalif astaxanthin business.

As EVP of Human Health & Nutrition, he will report to Matts Johansen, CEO of Aker BioMarine.

“We are excited to welcome Simon to the Human Health and Nutrition business area, said Matts Johansen, CEO of Aker BioMarine. “During his 3 years with us, Simon has proven that he is a capable leader and a valuable asset to our team. And since we recently initiated an accelerated growth plan for Superba krill oil, Simon will play a key role in the execution of our ambition.”

“I am looking forward to leading the Superba team and bringing continued success to our key markets in the Americas, Asia and Europe, said Simon Seward, EVP, Human Health & Nutrition, Aker BioMarine. “We have high growth ambitions and compelling commercial strategies for Superba krill oil over the next few years. By 2025, we are aiming to double our revenue and I am committed to lead the team to accomplish these goals.”